Journal of Controlled Release

Papers
(The H4-Index of Journal of Controlled Release is 83. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Intradermal delivery of the antiretroviral drugs cabotegravir and rilpivirine by dissolving microarray patches: Investigation of lymphatic uptake679
Branched pegylated linker-auristatin to control hydrophobicity for the production of homogeneous minibody-drug conjugate against HER2-positive breast cancer516
Enhancing gene transfection of poly(β-amino ester)s through modulation of amphiphilicity and chain sequence388
Inside Back Cover354
Outside Back Cover337
Targeting antibodies dissociate from drug delivery liposomes during blood circulation303
Smart theranostic contact lenses256
Recombinant collagen microneedles for transdermal delivery of antibacterial copper-DNA nanoparticles to treat skin and soft tissue infections246
Dual-responsive stem cell microspheres modified with BDNF for enhanced neural repair in diabetic erectile dysfunction243
Unveiling the drug delivery mechanism of graphene oxide dots at the atomic scale238
Design, evaluation, and in vitro–in vivo correlation of self-nanoemulsifying drug delivery systems to improve the oral absorption of exenatide235
Functional nanoplatform for modulating cellular forces to enhance antitumor immunity via mechanotransduction230
Enhancing calvarial defects repair with PDGF-BB mimetic peptide hydrogels229
Knocking down of Xkr8 enhances chemotherapy efficacy through modulating tumor immune microenvironment229
Targeted delivery of polymeric NO-donor micelles to hepatic stellate cells for restoration of liver function and inhibition of hepatic fibrosis224
Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy212
Gas-propelled anti-hair follicle aging microneedle patch for the treatment of androgenetic alopecia199
Core-shell vector-mediated co-delivery of CRISPR/Cas9 system and hydrophobic drugs against triple-negative breast cancer stem cells191
Hybrid prodrug nanoassembly for hypoxia-triggered immunogenic chemotherapy and immune modulation188
Orthogonal upconversion nanocarriers for combined photodynamic therapy and precisely triggered gene silencing in combating keloids172
Recent nanoengineered diagnostic and therapeutic advancements in management of Sepsis171
An antibacterial, multifunctional nanogel for efficient treatment of neutrophilic asthma171
Intraperitoneal drug delivery systems for peritoneal carcinomatosis: Bridging the gap between research and clinical implementation161
Fatty acid conjugated EPI-X4 derivatives with increased activity and in vivo stability160
Injectable dual thermoreversible hydrogel for sustained intramuscular drug delivery158
Dissolving microarray patches loaded with a rotigotine nanosuspension: A potential alternative to Neupro® patch156
Controlled bioorthogonal activation of Bromodomain-containing protein 4 degrader by co-delivery of PROTAC and Pd-catalyst for tumor-specific therapy154
Pickering emulsion-guided monomeric delivery of monophosphoryl lipid A for enhanced vaccination153
Engineered bacterial membrane vesicle as safe and efficient nano-heaters to reprogram tumor microenvironment for enhanced immunotherapy148
Biocompatible polymer-based micro/nanorobots for theranostic translational applications148
Systemically targeting monocytic myeloid-derived suppressor cells using dendrimers and their cell-level biodistribution kinetics145
ZIF-8-modified hydrogel sequentially delivers angiogenic and osteogenic growth factors to accelerate vascularized bone regeneration143
Novel lipid nanovesicle-loaded dissolving microarray patches for fenretinide in breast cancer chemoprevention140
Modified montmorillonite armed probiotics with enhanced on-site mucus-depleted intestinal colonization and H2S scavenging for colitis treatment138
Corrigendum to “Dissolving microarray patches loaded with a rotigotine nanosuspension: A potential alternative to Neupro® patch” [Journal of Controlled Release 372 (2024) 304–317]137
Publisher's note135
Outside Back Cover135
Outside Front Cover127
Engineered peptide-drug conjugate provides sustained protection of retinal ganglion cells with topical administration in rats126
Prediction of drug capturing by lipid emulsions in vivo for the treatment of a drug overdose125
Outside Back Cover123
Content list including Graphcal Abstracts123
Outside Back Cover122
Letter to the editor regarding “Translation of focused ultrasound for blood-brain barrier opening in glioma”120
Inside Back Cover120
Mechanisms of cellular retention of melanin bound drugs: Experiments and computational modeling116
Surgical management of peritoneal metastasis: Opportunities for pharmaceutical research115
Protein corona-driven nanovaccines improve antigen intracellular release and immunotherapy efficacy114
A tribute to my biosimilar114
Editorial Board112
Contents list including Graphcal Abstracts112
Inside Front Cover112
Editorial Board111
An injectable carrier for spatiotemporal and sequential release of therapeutic substances to treat myocardial infarction111
Antigen-specific T cell activation through targeted delivery of in-situ generated antigen and calcium ionophore to enhance antitumor immunotherapy109
Inside Front Cover108
Dynamic immuno-nanomedicines in oncology108
Outside Back Cover107
Control of cell penetration enhancer shielding and endosomal escape-kinetics crucial for efficient and biocompatible siRNA delivery107
A self-assembled graphene oxide adjuvant induces both enhanced humoral and cellular immune responses in influenza vaccine104
Content list including Graphcal Abstracts100
Outside Front Cover100
The pharmacokinetics of PEGylated liposomal doxorubicin are not significantly affected by sex in rats or humans, but may be affected by immune dysfunction98
Inside Back Cover97
Inside Front Cover97
Outside Front Cover97
Outside Front Cover95
Inside Back Cover95
Outside Back Cover95
Inside Front Cover94
Inside Back Cover92
Editorial Board91
Inside Back Cover89
Content list including Graphcal Abstracts88
Editorial Board88
Content list including Graphcal Abstracts87
Inside Front Cover87
Outside Back Cover86
Editorial Board86
Outside Back Cover86
Targeting therapy for prostate cancer by pharmaceutical and clinical pharmaceutical strategies84
Inside Back Cover84
Outside Back Cover84
Redox modulation with a perfluorocarbon nanoparticle to reverse Treg-mediated immunosuppression and enhance anti-tumor immunity83
“Click” amphotericin B in prodrug nanoformulations for enhanced systemic fungemia treatment83
Tumor permeable self-delivery nanodrug targeting mitochondria for enhanced chemotherapy83
0.095755100250244